Business Standard

Strides Arcolab unit, Pfenex in biosimilars JV

Agila Biotech will hold a 51% stake in the venture, but both parties will have equal say regarding product development and commercialisation

Reuters Mumbai

Agila Biotech, a unit of Indian drugmaker Strides Arcolab , and U.S.-based Pfenex Inc will develop and commercialise six biosimilars for global markets through a joint venture, the two companies said in a statement.

Agila Biotech will hold a 51% stake in the venture, but both parties will have equal say regarding product development and commercialisation, they said late on Tuesday.

 

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 17 2013 | 5:45 PM IST

Explore News